|
|
19 Apr 2002
By Financial Director
However, the decline was steeper in the US, where investment fell 65%, transaction volume fell 53% and pre-money valuations declined from EUR28.5m to EUR19m during the same period. Biopharmaceuticals saw a 13% increase in funding over the year, to EUR1.7bn euros in 160 deals.
advertisement
Have similiar articles delivered to your email box
Andy Craven, head of RMS at D&B; Jamie Campbell-Harris, CFO of Incisive Media; and Neil Morling, CFO of EC Harris, discuss credit risk
Our experts provide practical solutions to a number of challenges associated with successful cash management
advertisement
Email Newsletters
Email Newsletters
Please enter your email below to receive your profile link
advertisement
Search by job title, salary, or location - we only list senior financial roles
The Financial Director Summit 2012 will provide a unique platform in which to share, compare and contrast experiences whilst learning and networking with peers
Our experts provide practical solutions to a number of challenges associated with successful cash management
This paper delves into the many benefits that can be obtained by automating the supplier statement process
UNIT4 works with a huge variety of different organisations across several sectors, and this guide has been built on its experiences and knowledge.These tips will provide you with the tools you need to improve
David Cameron’s veto of the EU Treaty has been hailed as protecting UK business, but will frosty relationships with the EU harm trade, asks Neil Hodge...
